Beneficial effects of ketogenic diet in obese diabetic subjects

被引:117
作者
Dashti, Hussein M.
Mathew, Thazhumpal C.
Khadada, Mousa
Al-Mousawi, Mahdi
Talib, Husain
Asfar, Sami K.
Behbahani, Abdulla I.
Al-Zaid, Naji S.
机构
[1] Kuwait Univ, Fac Med, Dept Surg, Safat 13110, Kuwait
[2] Kuwait Univ, Fac Allied Hlth Sci, Safat 13110, Kuwait
[3] Kuwait Univ, Dept Med, Safat 13110, Kuwait
[4] Kuwait Univ, Primary Hlth Care Salmeiah & Shaab Clin, Safat 13110, Kuwait
[5] Kuwait Univ, Dept Physiol, Safat 13110, Kuwait
关键词
obesity; blood glucose; cholesterol; LDL; HDL; triglycerides; low-carbohydrate diet; ketogenic diet;
D O I
10.1007/s11010-007-9448-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective Obesity is closely linked to the incidence of type II diabetes. It is found that effective management of body weight and changes to nutritional habits especially with regard to the carbohydrate content and glycemic index of the diet have beneficial effects in obese subjects with glucose intolerance. Previously we have shown that ketogenic diet is quite effective in reducing body weight. Furthermore, it favorably alters the cardiac risk factors even in hyperlipidemic obese subjects. In this study the effect of ketogenic diet in obese subjects with high blood glucose level is compared to those with normal blood glucose level for a period of 56 weeks. Materials and methods A total of 64 healthy obese subjects with body mass index (BMI) greater than 30, having high blood glucose level and those subjects with normal blood glucose level were selected in this study. The body weight, body mass index, blood glucose level, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, urea and creatinine were determined before and at 8, 16, 24, 48, and 56 weeks after the administration of the ketogenic diet. Results The body weight, body mass index, the level of blood glucose, total cholesterol, LDL-cholesterol, triglycerides, and urea showed a significant decrease from week 1 to week 56 (P < 0.0001), whereas the level of HDL-cholesterol increased significantly (P < 0.0001). Interestingly these changes were more significant in subjects with high blood glucose level as compared to those with normal blood glucose level. The changes in the level of creatinine were not statistically significant. Conclusion This study shows the beneficial effects of ketogenic diet in obese diabetic subjects following its long-term administration. Furthermore, it demonstrates that in addition to its therapeutic value, low carbohydrate diet is safe to use for a longer period of time in obese diabetic subjects.
引用
收藏
页码:249 / 256
页数:8
相关论文
共 47 条
[1]   Body mass index of Kuwaiti children aged 3-9 years: reference percentiles and curves [J].
Al-Isa, Abdulwahab Naser ;
Thalib, Lukman .
JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH, 2006, 126 (01) :41-46
[2]  
Al-Isa Abdulwahab Naser, 2003, Nutrition and Health (Bicester), V17, P185
[3]   Ageing and the Mediterranean diet: a review of the role of dietary fats [J].
Battino, M ;
Ferreiro, MS .
PUBLIC HEALTH NUTRITION, 2004, 7 (07) :953-958
[4]   CHANGES IN BODY COMPOSITION DURING WEIGHT REDUCTION IN OBESITY - BALANCE STUDIES COMPARING EFFECTS OF FASTING AND A KETOGENIC DIET [J].
BENOIT, FL ;
MARTIN, RL ;
WATTEN, RH .
ANNALS OF INTERNAL MEDICINE, 1965, 63 (04) :604-+
[5]   The effects of carbohydrate variation in isocaloric diets on glycogenolysis and gluconeogenesis in healthy men [J].
Bisschop, PH ;
Arias, AMP ;
Ackermans, MT ;
Endert, E ;
Pijl, H ;
Kuipers, F ;
Meijer, AJ ;
Sauerwein, HP ;
Romijn, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05) :1963-1967
[6]  
Bisschop PH, 2001, AM J CLIN NUTR, V73, P554
[7]   Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes [J].
Boden, G ;
Sargrad, K ;
Homko, C ;
Mozzoli, M ;
Stein, TP .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (06) :403-411
[8]   Medical consequences of obesity [J].
Bray, GA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2583-2589
[9]  
BRAY GA, 1976, RISKS DISADVANTAGES, P215
[10]  
Colditz G A, 1995, J Am Med Womens Assoc (1972), V50, P40